Gomberg-Maitland M - Search Results

1

Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.

Zhang ZN, Jiang X, Zhang R, Li XL, Wu BX, Zhao QH, Wang Y, Dai LZ, Pan L, Gomberg-Maitland M, Jing ZC. Zhang ZN, et al. Heart. 2011 Nov;97(22):1876-81. doi: 10.1136/heartjnl-2011-300344. Epub 2011 Sep 21. Heart. 2011. PMID: 21948962 Clinical Trial.

2

Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension.

Sun PY, Jiang X, Gomberg-Maitland M, Zhao QH, He J, Yuan P, Zhang R, Jing ZC. Sun PY, et al. Chest. 2012 Feb;141(2):374-380. doi: 10.1378/chest.10-3331. Epub 2011 Jul 21. Chest. 2012. PMID: 21778258

3

Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.

Jiang R, Ai ZS, Jiang X, Yuan P, Liu D, Zhao QH, He J, Wang L, Gomberg-Maitland M, Jing ZC. Jiang R, et al. Hypertens Res. 2015 Aug;38(8):539-44. doi: 10.1038/hr.2015.33. Epub 2015 Mar 19. Hypertens Res. 2015. PMID: 25787034

4

Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial.

Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, Barst RJ. Tapson VF, et al. Chest. 2006 Mar;129(3):683-8. doi: 10.1378/chest.129.3.683. Chest. 2006. PMID: 16537868 Clinical Trial.

5

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Benza RL, Gomberg-Maitland M, Demarco T, Frost AE, Torbicki A, Langleben D, Pulido T, Correa-Jaque P, Passineau MJ, Wiener HW, Tamari M, Hirota T, Kubo M, Tiwari HK. Benza RL, et al. Am J Respir Crit Care Med. 2015 Dec 1;192(11):1345-54. doi: 10.1164/rccm.201501-0196OC. Am J Respir Crit Care Med. 2015. PMID: 26252367 Free PMC article.

6

Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial.

Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Preston IR, et al. J Heart Lung Transplant. 2020 May;39(5):464-472. doi: 10.1016/j.healun.2019.12.008. Epub 2020 Jan 21. J Heart Lung Transplant. 2020. PMID: 32008947 Clinical Trial.

7

Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.

Gomberg-Maitland M, Tapson VF, Benza RL, McLaughlin VV, Krichman A, Widlitz AC, Barst RJ. Gomberg-Maitland M, et al. Am J Respir Crit Care Med. 2005 Dec 15;172(12):1586-9. doi: 10.1164/rccm.200505-766OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151039 Clinical Trial.

8

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.

Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S. Gomberg-Maitland M, et al. Am J Cardiol. 2005 Nov 1;96(9):1334-6. doi: 10.1016/j.amjcard.2005.06.083. Epub 2005 Sep 16. Am J Cardiol. 2005. PMID: 16253609 Clinical Trial.

9

One-year experience with intravenous treprostinil for pulmonary arterial hypertension.

Benza RL, Tapson VF, Gomberg-Maitland M, Poms A, Barst RJ, McLaughlin VV. Benza RL, et al. J Heart Lung Transplant. 2013 Sep;32(9):889-96. doi: 10.1016/j.healun.2013.06.008. J Heart Lung Transplant. 2013. PMID: 23953817 Clinical Trial.

10

Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.

Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Hill NS, et al. Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS. Ann Am Thorac Soc. 2015. PMID: 25590376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters